Agree with you, my concern is the dilution.
If erb can pull one of these funding options you stated above, we would easily move up.
Which is our first priority as we need money to continue, Protocol later this year, and fda approval late this year or early next year, always sooner the better but these things take time
Why number one issue is funding right now without diluting the crap out of us
Sell the company and be done with it?, page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)